SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 301 filers reported holding SEATTLE GENETICS INC in Q2 2017. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $5,941,000 | +7.6% | 30,358 | -6.5% | 0.01% | 0.0% |
| Q2 2020 | $5,519,000 | +67.2% | 32,481 | +13.6% | 0.01% | +40.0% |
| Q1 2020 | $3,300,000 | +59.0% | 28,601 | +57.4% | 0.01% | +66.7% |
| Q4 2019 | $2,076,000 | +88.2% | 18,170 | +40.7% | 0.00% | +50.0% |
| Q3 2019 | $1,103,000 | +4.1% | 12,912 | -15.7% | 0.00% | 0.0% |
| Q2 2019 | $1,060,000 | -35.4% | 15,313 | -31.6% | 0.00% | 0.0% |
| Q1 2019 | $1,640,000 | +18.5% | 22,391 | -8.3% | 0.00% | 0.0% |
| Q4 2018 | $1,384,000 | -18.8% | 24,429 | +10.5% | 0.00% | -33.3% |
| Q3 2018 | $1,705,000 | +25.2% | 22,103 | +7.7% | 0.00% | +50.0% |
| Q2 2018 | $1,362,000 | +182.0% | 20,516 | +122.5% | 0.00% | +100.0% |
| Q1 2018 | $483,000 | +55.8% | 9,220 | +59.0% | 0.00% | 0.0% |
| Q4 2017 | $310,000 | -18.0% | 5,800 | -16.5% | 0.00% | 0.0% |
| Q3 2017 | $378,000 | -10.8% | 6,950 | -15.2% | 0.00% | 0.0% |
| Q2 2017 | $424,000 | -42.3% | 8,191 | -30.0% | 0.00% | -50.0% |
| Q1 2017 | $735,000 | +21.7% | 11,700 | +2.2% | 0.00% | 0.0% |
| Q4 2016 | $604,000 | +20.6% | 11,449 | +23.5% | 0.00% | +100.0% |
| Q3 2016 | $501,000 | +24.9% | 9,267 | -6.6% | 0.00% | 0.0% |
| Q2 2016 | $401,000 | +26.1% | 9,917 | +9.4% | 0.00% | 0.0% |
| Q1 2016 | $318,000 | -56.7% | 9,067 | -40.3% | 0.00% | -66.7% |
| Q2 2015 | $735,000 | +11.9% | 15,188 | -18.2% | 0.00% | 0.0% |
| Q1 2015 | $657,000 | +33.5% | 18,572 | +21.4% | 0.00% | +50.0% |
| Q4 2014 | $492,000 | -78.2% | 15,298 | -69.1% | 0.00% | -86.7% |
| Q1 2014 | $2,256,000 | +0.4% | 49,524 | -12.1% | 0.02% | -11.8% |
| Q4 2013 | $2,247,000 | -15.7% | 56,318 | -7.4% | 0.02% | -26.1% |
| Q3 2013 | $2,666,000 | +53.4% | 60,829 | +10.1% | 0.02% | +43.8% |
| Q2 2013 | $1,738,000 | – | 55,245 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |